Myo-inositol therapy for poor-responders during IVF: A prospective controlled observational trial

Journal of Ovarian Research

Volumn 8, Issue 1, 2015, Pages

  Caprio, Francesca ^a   D'Eufemia, Maria Diletta ^a   Trotta, Carlo ^a   Campitiello, Maria Rosaria ^a   Ianniello, Raffaele ^a   Mele, Daniela ^a   Colacurci, Nicola ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

IVF; Myo inositol; Ovarian sensitivity index; Poor responder

Indexed keywords

ESTRADIOL; FOLIC ACID; GONADOTROPIN; INOSITOL;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CELL COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FERTILIZATION IN VITRO; FERTILIZATION RATE; GENITAL SYSTEM DISEASE ASSESSMENT; GONADOTROPIN BLOOD LEVEL; HUMAN; IMPLANTATION RATE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; OBSERVATIONAL STUDY; OOCYTE MATURATION; OOCYTE QUALITY; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARIAN SENSITIVITY INDEX; OVARY FUNCTION; PATIENT COMPLIANCE; PILOT STUDY; POPULATION PRODUCTIVITY; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; CLINICAL TRIAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; IN VITRO FERTILIZATION; OOCYTE; OVULATION INDUCTION; PREGNANCY; PROCEDURES;

ADULT; FEMALE; FERTILIZATION IN VITRO; FOLIC ACID; GONADOTROPINS; HUMANS; INOSITOL; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84930934067     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/s13048-015-0167-x     Document Type: Article

References (23)

1. Wide L. Follicle-stimulating hormones in anterior pituitary gland from children and adults differ in relation to sex and age. J Endocrinol. 1989;123:519-29.
2. Kailasam C, Keay SD, Wilson P, Ford WCL, Jenkins JM. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome. Hum Reprod. 2004;19(7):1544-7.
3. Fasouliotis SJ, Simon A, Laufer N. Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet. J Assist Reprod Genet. 2000;17:357-73.
4. Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S. Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev. 2010;1, CD004379.
5. Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet. 2008;25:123-7.
6. Kyrou D, Kolibianakis EM, Venetis CA, Papanilolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systrmatic review and meta-analysis. Fertil Steril. 2009;91:749-66.
7. Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009;7:101.
8. Colacurci N, Caprio F, La Verde E, Trotta C, Ianniello R, Mele D, et al. Sequential protocol with urinary-FSH/recombinant-FSH versus standard protocol with recombinant-FSH in women of advanced age undergoing IVF. Gynecol Endocrinol. 2014;30(10):730-3.
9. Kutateladze TG. Translation of the phosphoinositide code by PI effectors. Nat Chem Biol. 2011;6(7):507-13.
10. Unfer V, Carlomagno G, Dante G, Facchinetti F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012;28(7):509-15.
11. Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013;95(10):1811-27.
12. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D chiro inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314-20.
13. Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L. Myo-inositol may improce oocyte quality in intracitoplasmic sperm injectioncycles. A prospective, controlled randomized trial. Fertil Steril. 2009;91(5):1750-4.
14. Jiang WD, Wu P, Kuang SY, Liu Y, Jiang J, Hu K, et al. Myo-inositol prevents copper-induced oxidative damage and changes in antioxidant capacity in various organs and the enterocytes of juvenile Jian carp (Cyprinus carpio var. Jian). Aquat Toxicol. 2011;5(3-4):543-51.
15. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur Rev Med Pharmacol Sci. 2011;15(5):509-14.
16. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616-24.
17. Unfer V, Raffone E, Rizzo P, Buffo S. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011;27(11):857-61.
18. Devroey P, Tjandraprawira K, Mannaerts B, Coelingh Bennink H, Smitz J, Bonduelle M, et al. A randomized, assessor-blind, group- omparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum Reprod. 1995;10:332-7.
19. Devroey P, van Steirteghem A. A review of ten years experience of ICSI. Hum Reprod Update. 2004;10:19-28.
20. Chiu TT, Tam PP. A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum. JAssist Reprod Genet. 1992;9:524-30.
21. Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002;17(6):1591-6.
22. Chiu TT, Rogers MS, Briton-Jones C, Haines C. Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes. Hum Reprod. 2003;18(2):408-16.
23. Goud PT, Goud AP, Oostveldt PV, Dhont M. Presence and dynamic redistribution of type I inositol, 1,4,5-triphosphate receptor in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage division. Mol Hum Reprod. 1999;5:441-51.